Published: June 2026 (preprint, not yet peer reviewed)
Key Takeaways
Researchers compared how psilocybin therapy and the antidepressant escitalopram changed brain organization in people with major depressive disorder.
Rather than measuring brain activity alone, the team used computer models to test how the brain would respond to simulated disturbances.
Psilocybin treatment was associated with greater brain reorganization in response to these virtual perturbations.
Escitalopram treatment was associated with reduced brain reorganization, suggesting more stable brain dynamics.
These findings do not show that one treatment is better than the other. They suggest the treatments may improve depression through different biological mechanisms.
Why Study Brain Flexibility?
The human brain is constantly balancing two important abilities:
Remaining stable enough to support everyday thinking and behavior.
Remaining flexible enough to adapt when circumstances change.
Researchers believe this balance may be disrupted in major depressive disorder (MDD). Some brain networks may become overly rigid, making it harder to shift away from repetitive negative thoughts or emotional patterns.
This new study explored whether two effective depression treatments, psilocybin and escitalopram, restore that balance in different ways.
What Did Researchers Do?
The study analyzed resting-state functional MRI (fMRI) scans collected before and after treatment in participants with depression.
Instead of looking only at the brain scans themselves, researchers created individualized computer models of each participant's brain.
They then introduced thousands of small, virtual "perturbations," essentially simulated disturbances, into these models to observe how easily brain networks reorganized.
Think of it like gently tapping different parts of a complex machine to see how the entire system responds.
The researchers summarized this response using a measurement called the Brain Network Reconfiguration Index (NRI). A higher NRI indicates the brain reorganizes more readily after a disturbance, while a lower NRI suggests the brain's organization changes less.
What Did the Study Find?
The two treatments produced opposite patterns.
After psilocybin treatment
Researchers observed:
Higher global Brain Network Reconfiguration Index (NRI)
Greater ability for brain networks to reorganize following simulated perturbations
Increased flexibility in regions involved in coordinating large-scale brain activity
The authors suggest this pattern reflects greater adaptability of brain network dynamics after treatment.
After escitalopram treatment
Researchers observed:
Lower global NRI
Reduced network reorganization following perturbation
More stable patterns of brain organization
The authors interpret this as evidence that escitalopram may stabilize brain dynamics rather than increasing flexibility.
Does More Flexibility Mean Better?
Not necessarily.
It might seem intuitive that a more flexible brain is always healthier, but neuroscience is more complicated.
Healthy brain function depends on maintaining an appropriate balance between flexibility and stability. Too much rigidity can make adaptation difficult, while too much instability can also interfere with normal functioning.
The current study does not suggest that higher NRI is inherently superior to lower NRI. Instead, it indicates that these two depression treatments may help patients through different patterns of brain reorganization.
Why Is This Different From Earlier Research?
Many previous brain imaging studies measured changes in functional connectivity, or which brain regions become active together.
This study went a step further.
Instead of asking, "How is the brain functioning right now?", researchers asked,
"How would this brain respond if it were challenged?"
Using computer simulations allowed investigators to estimate how resilient or adaptable different brain networks may be after treatment.
This systems-level approach could eventually help researchers better understand why different people respond differently to depression treatments.
Important Limitations
Several limitations should be considered.
This is a preprint and has not yet completed peer review.
The perturbations were computer simulations rather than real interventions applied to the brain.
The Brain Network Reconfiguration Index is a research measure and is not used clinically.
The study examined changes in brain network dynamics after treatment, not permanent structural changes to the brain.
The findings do not establish that increased flexibility directly causes improvements in depression symptoms.
What This Means
This study adds to growing evidence that psilocybin and conventional antidepressants may improve depression through different changes in brain function.
Rather than asking which treatment is "better," the research suggests each may shift brain dynamics in its own way. Psilocybin was associated with greater capacity for network reorganization after simulated disturbances, while escitalopram was associated with greater stability.
As researchers continue studying these mechanisms, tools like the Brain Network Reconfiguration Index may help improve our understanding of how different treatments affect the brain and why individual responses can vary.
Because this research is still in the preprint stage, these findings should be viewed as promising but preliminary until they have been independently reviewed and replicated